Related Experiment Video

Updated: Jul 22, 2026

Isolation of Translating Ribosomes Containing Peptidyl-tRNAs for Functional and Structural Analyses
11:19

Isolation of Translating Ribosomes Containing Peptidyl-tRNAs for Functional and Structural Analyses

Published on: February 25, 2011

Arrest of respiration induced by polypeptide antibiotics

V Sobek

    Arzneimittel-Forschung
    |January 1, 1982
    PubMed

    Insights

    Polymyxin B blocks acetylcholine receptors, causing post-synaptic neuromuscular blockade. This action has no antagonists and increases the risk of respiratory arrest.

    Area of Science:

    • Pharmacology
    • Neuroscience
    • Toxicology

    Background:

    • Polymyxin B is an antibiotic known to affect neuromuscular transmission.
    • Its post-synaptic mechanism involves blocking acetylcholine receptors.

    Purpose of the Study:

    • To elucidate the specific mechanisms by which Polymyxin B induces neuromuscular blockade.
    • To investigate the potential for antagonism or resistance to Polymyxin B's effects.

    Main Methods:

    • The study focuses on the post-synaptic actions of Polymyxin B at the neuromuscular junction.
    • Investigated interactions with other neuromuscular blocking agents and ions.

    Main Results:

    • Polymyxin B induces a post-synaptic neuromuscular block that is not antagonized by standard antagonists.
    • Demonstrated resistance to neostigmine and calcium, indicating unique blockade characteristics.
    • Highlighted an increased risk of respiratory arrest due to these properties.

    Conclusions:

    • Polymyxin B's neuromuscular blockade is irreversible by conventional means.
    • Clinicians should be aware of the heightened risk of respiratory compromise with Polymyxin B administration.
    • Further research into potential interventions for Polymyxin B-induced neuromuscular blockade is warranted.

    More Related Videos

    Isolation of Ribosome Bound Nascent Polypeptides in vitro to Identify Translational Pause Sites Along mRNA10:15

    Isolation of Ribosome Bound Nascent Polypeptides in vitro to Identify Translational Pause Sites Along mRNA

    Published on: July 6, 2012

    Using SecM Arrest Sequence as a Tool to Isolate Ribosome Bound Polypeptides09:42

    Using SecM Arrest Sequence as a Tool to Isolate Ribosome Bound Polypeptides

    Published on: June 19, 2012

    Related Concept Videos

    Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

    Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

    Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
    Although all competitive neuromuscular blockers are designed...
    Depolarizing Blockers: Mechanism of Action01:28

    Depolarizing Blockers: Mechanism of Action

    Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
    Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
    Skeletal Muscle Relaxants: Therapeutic Uses01:31

    Skeletal Muscle Relaxants: Therapeutic Uses

    Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
    Acute Respiratory Failure-III01:30

    Acute Respiratory Failure-III

    Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
    Acute Respiratory Failure-IV01:23

    Acute Respiratory Failure-IV

    Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
    Inhibitors of Bacterial Protein Synthesis01:25

    Inhibitors of Bacterial Protein Synthesis

    Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...